Amylase & Lipase: Pancreatitis Tests

Why These Tests Matter

Amylase vs Lipase: Which Is Better?

Diagnosis of Acute Pancreatitis (Requires 2 of 3)

• Characteristic abdominal pain (severe epigastric pain radiating to the back)
• Amylase or lipase >3× the upper limit of normal
• Characteristic findings on CT/MRI/ultrasound imaging

Frequently asked questions

References

The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.

1. Acute Pancreatitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK482468

References

Sources cited on this page. PubMed links open the original abstract.

1. Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379–2400. PMID 16709331 · doi:10.1111/j.1572-0241.2006.00856.x

Amylase versus lipase – which test matters more?

Both amylase and lipase are released by an inflamed pancreas. Historically amylase was the go-to test for pancreatitis, but lipase has largely replaced it in modern clinical practice for two reasons. First, lipase remains elevated longer – up to 7–14 days after symptom onset versus 3–5 days for amylase – which matters when patients present late. Second, lipase is more specific for the pancreas; amylase is also produced by salivary glands, the fallopian tubes, and other tissues, so elevated amylase can result from mumps, ectopic pregnancy, or intestinal obstruction without any pancreatic disease.

Most major laboratories now only request lipase for suspected pancreatitis, and clinical guidelines from the American College of Gastroenterology and the UK Joint British Societies no longer recommend routine amylase measurement unless lipase is unavailable. The diagnosis of acute pancreatitis requires lipase (or amylase) more than three times the upper limit of normal, combined with characteristic abdominal pain – a rise in enzyme alone is not sufficient.

When amylase is elevated but the pancreas is normal

Macroamylasaemia is a benign condition in which amylase forms complexes with immunoglobulins, producing a persistently elevated serum amylase despite no pancreatic disease. These large complexes cannot be filtered by the kidney, so urinary amylase is low while serum amylase is high – the opposite pattern from pancreatitis. Macroamylasaemia is found in roughly 1% of healthy adults and requires no treatment; the key is recognising it to avoid unnecessary investigation. The amylase-to-creatinine clearance ratio (ACCR) can help distinguish it from true pancreatitis.

Severity grading in pancreatitis – what amylase does not tell you

The height of the amylase or lipase elevation does not correlate with the severity of pancreatitis. A patient with a mildly elevated amylase can have severe necrotising pancreatitis, and vice versa. Severity assessment uses scoring systems (Ranson criteria, Glasgow–Imrie score, or the bedside BISAP score) and CT imaging (Balthazar grade). Early markers of severe disease include CRP above 150 mg/L at 48 hours, haematocrit above 44%, rising creatinine, and persistent organ failure at 48 hours.